ArticleCureus2025
A Financial Benefit-Cost Analysis of Advancing Jordan's Medical Tourism: The Case of Proton Therapy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Assessing the scope and reporting quality of published health economic evaluation studies in Jordan: a systematic literature review.Health economics review · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives Jordan is moving forward toward enhancing medical tourism. Proton therapy (PT), an effective intervention for cancer treatment, is unavailable in some countries, often necessitating international travel to receive treatment. This study aims to evaluate the cost-benefit of establishing a PT facility in Jordan to address this gap. Our study is one of the first studies to evaluate the economic impact of medical tourism through establishing a PT facility, showing its potential to position Jordan as a regional hub for advanced medical care. Methods We conducted a financial benefit-cost analysis using an ex-ante analysis model. The analysis was conducted from two distinct perspectives: the healthcare payer perspective and the societal perspective. Model inputs were derived through a literature search and questionnaires completed by local experts. Deterministic sensitivity analysis (DSA) and probabilistic sensitivity analysis (PSA) were used to assess model robustness and explore key uncertainties. To overcome uncertainty in projected user numbers, two scenarios were created: a conservative scenario with average capacity, and an optimistic scenario based on maximum device utilization. Results The benefit-cost ratio (BCR) of establishing the facility was 1.24 from the societal perspective. This perspective showed a net present value (NPV) of 15 million Jordanian dinars (JOD), an internal rate of return (IRR) of 12%, and a payback period of seven years. From the public payer perspective, values were less favorable, but still positive, with a BCR of 1.08, an NPV of 5 million JOD, an IRR of 6%, and a payback period of nine years. Scenario analyses showed that, if the device is utilized to its maximum capacity, the benefit would increase reaching BCRs of 1.80 and 1.58 from the societal and healthcare payer perspectives, respectively. DSA and PSA proved the robustness of the model results. Conclusions The model shows that establishing a PT facility in Jordan is cost-effective, and is expected to generate substantial economic returns, making it a justifiable investment decision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.